Sanofi Logo

Sanofi

ISIN: FR0000120578 | Ticker: SAN | LEI: 549300E9PC51EN656011
Sector: Health CareSub-Industry: Pharmaceuticals
Country: France

About Sanofi

Company Description

Sanofi S.A. is a French multinational healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur).

Year founded

1973

Served area

Worldwide

Headcount

100,000

Headquarters

54 Rue la Boétie, 75008 Paris – France

Financial statements

Download as Excel
Line item in (eur) 01.01.2019 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 112,630,000,000.00 114,413,000,000.00 120,242,000,000.00 126,722,000,000.00
Noncurrent Assets N/A 83,694,000,000.00 80,627,000,000.00 89,589,000,000.00 92,611,000,000.00
Property Plant And Equipment N/A 9,717,000,000.00 9,365,000,000.00 10,028,000,000.00 9,869,000,000.00
Goodwill N/A 44,519,000,000.00 44,364,000,000.00 48,056,000,000.00 49,892,000,000.00
Intangible Assets Other Than Goodwill N/A 16,509,000,000.00 18,341,000,000.00 21,407,000,000.00 21,640,000,000.00
Investment Accounted For Using Equity Method N/A 3,591,000,000.00 201,000,000.00 250,000,000.00 677,000,000.00
Deferred Tax Assets N/A 5,391,000,000.00 4,176,000,000.00 4,598,000,000.00 5,381,000,000.00
Current Tax Assets Noncurrent N/A 164,000,000.00 248,000,000.00 175,000,000.00 242,000,000.00
Other Noncurrent Assets N/A 2,503,000,000.00 2,734,000,000.00 3,127,000,000.00 3,095,000,000.00
Inventories N/A 7,994,000,000.00 8,352,000,000.00 8,715,000,000.00 8,960,000,000.00
Current Trade Receivables N/A 7,937,000,000.00 7,491,000,000.00 7,568,000,000.00 8,424,000,000.00
Current Tax Assets Current N/A 808,000,000.00 1,208,000,000.00 612,000,000.00 374,000,000.00
Cash and cash equivalents 6,925,000,000.00 9,427,000,000.00 13,915,000,000.00 10,098,000,000.00 12,736,000,000.00
Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 28,611,000,000.00 33,703,000,000.00 30,564,000,000.00 34,026,000,000.00
Noncurrent Assets Or Disposal Groups Classified As Held For Sale N/A 325,000,000.00 83,000,000.00 89,000,000.00 85,000,000.00
Other Current Assets N/A 2,445,000,000.00 2,737,000,000.00 3,571,000,000.00 3,532,000,000.00
Equity And Liabilities N/A 112,630,000,000.00 114,413,000,000.00 120,242,000,000.00 126,722,000,000.00
Equity 59,175,000,000.00 59,230,000,000.00 63,252,000,000.00 69,031,000,000.00 75,152,000,000.00
Equity Attributable To Owners Of Parent N/A 59,056,000,000.00 63,106,000,000.00 68,681,000,000.00 74,784,000,000.00
Noncontrolling Interests N/A 174,000,000.00 146,000,000.00 350,000,000.00 368,000,000.00
Noncurrent Liabilities N/A 33,013,000,000.00 31,881,000,000.00 29,916,000,000.00 27,596,000,000.00
Deferred Tax Liabilities N/A 2,294,000,000.00 1,770,000,000.00 1,617,000,000.00 1,841,000,000.00
Current Tax Liabilities Noncurrent N/A 1,680,000,000.00 1,733,000,000.00 2,039,000,000.00 1,979,000,000.00
Longterm Borrowings N/A 20,131,000,000.00 19,745,000,000.00 17,123,000,000.00 14,857,000,000.00
Trade And Other Current Payables To Trade Suppliers N/A 5,313,000,000.00 5,295,000,000.00 6,180,000,000.00 6,813,000,000.00
Current Tax Liabilities Current N/A 258,000,000.00 604,000,000.00 309,000,000.00 574,000,000.00
Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale N/A 20,381,000,000.00 19,248,000,000.00 21,295,000,000.00 23,964,000,000.00
Liabilities Included In Disposal Groups Classified As Held For Sale N/A 6,000,000.00 32,000,000.00 0.00 10,000,000.00
Current Borrowings And Current Portion Of Noncurrent Borrowings N/A 4,554,000,000.00 2,767,000,000.00 3,183,000,000.00 4,174,000,000.00
Line item in (eur) 01.01.2019/
01.01.2020
01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue From Sale Of Goods 36,126,000,000.00 36,041,000,000.00 37,761,000,000.00 42,997,000,000.00
Other Revenue 1,505,000,000.00 1,328,000,000.00 1,414,000,000.00 2,392,000,000.00
Profit Loss From Operating Activities 3,051,000,000.00 14,113,000,000.00 8,126,000,000.00 10,656,000,000.00
Finance Income 141,000,000.00 53,000,000.00 40,000,000.00 206,000,000.00
Finance Costs 440,000,000.00 388,000,000.00 368,000,000.00 440,000,000.00
Income Tax Expense Continuing Operations 121,000,000.00 1,807,000,000.00 1,558,000,000.00 2,006,000,000.00
Profit Loss From Continuing Operations 2,886,000,000.00 12,330,000,000.00 6,279,000,000.00 N/A
Profit Loss From Discontinued Operations -101,000,000.00 0.00 0.00 N/A
Profit (loss) 2,785,000,000.00 12,330,000,000.00 6,279,000,000.00 8,484,000,000.00
Profit Loss Attributable To Owners Of Parent 2,754,000,000.00 12,294,000,000.00 6,223,000,000.00 8,371,000,000.00
Profit Loss Attributable To Noncontrolling Interests 31,000,000.00 36,000,000.00 56,000,000.00 113,000,000.00
Line item in (eur) 01.01.2019 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A 2,785,000,000.00 12,330,000,000.00 6,279,000,000.00 8,484,000,000.00
Adjustments For Decrease Increase In Inventories N/A -547,000,000.00 -593,000,000.00 -357,000,000.00 -927,000,000.00
Adjustments For Increase Decrease In Trade Account Payable N/A 169,000,000.00 86,000,000.00 451,000,000.00 452,000,000.00
Adjustments For Sharebased Payments N/A 252,000,000.00 274,000,000.00 244,000,000.00 245,000,000.00
Adjustments For Losses Gains On Disposal Of Noncurrent Assets N/A -286,000,000.00 -301,000,000.00 -300,000,000.00 -711,000,000.00
Other Adjustments To Reconcile Profit Loss N/A -309,000,000.00 -711,000,000.00 -57,000,000.00 138,000,000.00
Interest Paid Classified As Operating Activities N/A 379,000,000.00 315,000,000.00 334,000,000.00 380,000,000.00
Interest Received Classified As Operating Activities N/A 92,000,000.00 37,000,000.00 3,000,000.00 173,000,000.00
Income Taxes Paid Refund Classified As Operating Activities N/A 1,695,000,000.00 2,051,000,000.00 1,280,000,000.00 2,452,000,000.00
Cash Flows From Used In Operating Activities N/A 7,715,000,000.00 7,418,000,000.00 10,522,000,000.00 10,526,000,000.00
Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A N/A 0.00 42,000,000.00 134,000,000.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 488,000,000.00 5,336,000,000.00 5,594,000,000.00 992,000,000.00
Cash Flows From Used In Investing Activities N/A -1,183,000,000.00 3,619,000,000.00 -7,298,000,000.00 -2,075,000,000.00
Payments From Changes In Ownership Interests In Subsidiaries N/A 7,000,000.00 0.00 0.00 N/A
Proceeds From Issuing Shares N/A 162,000,000.00 203,000,000.00 186,000,000.00 188,000,000.00
Payments To Acquire Or Redeem Entitys Shares N/A 9,000,000.00 822,000,000.00 382,000,000.00 497,000,000.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 267,000,000.00 234,000,000.00 149,000,000.00 291,000,000.00
Cash Flows From Used In Financing Activities N/A -4,193,000,000.00 -6,485,000,000.00 -7,056,000,000.00 -5,821,000,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A 9,000,000.00 -64,000,000.00 15,000,000.00 8,000,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes N/A 2,502,000,000.00 4,488,000,000.00 -3,817,000,000.00 2,638,000,000.00
Cash and cash equivalents 6,925,000,000.00 9,427,000,000.00 13,915,000,000.00 10,098,000,000.00 12,736,000,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
FRA
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
FRA
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2020

Report
Q1
H1
Q3
FY
Consolidated Report
FRA
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
02.05.24 None Other Buy EUR 0.00
26.04.24 None Other Buy EUR 91,380.00
09.06.23 None Other Buy EUR 856.04
02.05.23 None Other Buy EUR 6,364,008.00
02.05.23 None Other Buy EUR 48,835.00

Capital markets information

ISIN

FR0000120578

LEI

549300E9PC51EN656011

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

Euronext Paris

Stock Index

CAC40

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.